Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones

Andreas I. Constantinou, Rajendra G. Mehta, Andrew T M Vaughan

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. We used the N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis animal model to test the effectiveness of these two isoflavones as chemopreventive agents. Each isoflavone was injected daily into 35-day-old rats for six months while we monitored the animals' body weight and mammary tumor appearance. Genistein was effective in reducing tumor multiplicity, but it reduced tumor incidence only marginally. Daidzein was less effective in reducing both tumor incidence and multiplicity. To investigate genistein's mechanism of action we determined the topoisomerase II (topo II) activity and detected the phosphotyrosine-containing peptides in the extracts of mammary tissues isolated from control and isoflavone-treated animals. Mammary tumors contained over 60-fold higher topo II enzymatic activity than the mammary glands. Similarly, more tyrosine phosphopeptides were detectable in mammary tumors than in mammary glands. Tissue samples from genistein treated animals contained similar topo II and protein tyrosine kinase (PTK) activities as the control group. These data suggest that mammary tumorigenesis is accompanied by an extensive increase in topo II and PTK activities. The mechanism of chemoprevention by genistein, however, is independent of topo II or PTK inhibition.

Original languageEnglish (US)
Pages (from-to)3293-3298
Number of pages6
JournalAnticancer Research
Volume16
Issue number6 A
StatePublished - 1996
Externally publishedYes

Fingerprint

Methylnitrosourea
Isoflavones
Genistein
Type II DNA Topoisomerase
Soybeans
Breast Neoplasms
Protein-Tyrosine Kinases
Breast
Human Mammary Glands
Prostatic Neoplasms
Carcinogenesis
Diet
Phosphopeptides
Neoplasms
Phosphotyrosine
Tissue Extracts
Incidence
Chemoprevention
Tyrosine
Animal Models

Keywords

  • Carcinogenesis
  • Chemoprevention
  • Isoflavones
  • Protein tyrosine kinase
  • Topoisomerase II

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. / Constantinou, Andreas I.; Mehta, Rajendra G.; Vaughan, Andrew T M.

In: Anticancer Research, Vol. 16, No. 6 A, 1996, p. 3293-3298.

Research output: Contribution to journalArticle

Constantinou, Andreas I. ; Mehta, Rajendra G. ; Vaughan, Andrew T M. / Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. In: Anticancer Research. 1996 ; Vol. 16, No. 6 A. pp. 3293-3298.
@article{4fc007e9470741e49b2a4895ace4f120,
title = "Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones",
abstract = "Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. We used the N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis animal model to test the effectiveness of these two isoflavones as chemopreventive agents. Each isoflavone was injected daily into 35-day-old rats for six months while we monitored the animals' body weight and mammary tumor appearance. Genistein was effective in reducing tumor multiplicity, but it reduced tumor incidence only marginally. Daidzein was less effective in reducing both tumor incidence and multiplicity. To investigate genistein's mechanism of action we determined the topoisomerase II (topo II) activity and detected the phosphotyrosine-containing peptides in the extracts of mammary tissues isolated from control and isoflavone-treated animals. Mammary tumors contained over 60-fold higher topo II enzymatic activity than the mammary glands. Similarly, more tyrosine phosphopeptides were detectable in mammary tumors than in mammary glands. Tissue samples from genistein treated animals contained similar topo II and protein tyrosine kinase (PTK) activities as the control group. These data suggest that mammary tumorigenesis is accompanied by an extensive increase in topo II and PTK activities. The mechanism of chemoprevention by genistein, however, is independent of topo II or PTK inhibition.",
keywords = "Carcinogenesis, Chemoprevention, Isoflavones, Protein tyrosine kinase, Topoisomerase II",
author = "Constantinou, {Andreas I.} and Mehta, {Rajendra G.} and Vaughan, {Andrew T M}",
year = "1996",
language = "English (US)",
volume = "16",
pages = "3293--3298",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 A",

}

TY - JOUR

T1 - Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones

AU - Constantinou, Andreas I.

AU - Mehta, Rajendra G.

AU - Vaughan, Andrew T M

PY - 1996

Y1 - 1996

N2 - Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. We used the N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis animal model to test the effectiveness of these two isoflavones as chemopreventive agents. Each isoflavone was injected daily into 35-day-old rats for six months while we monitored the animals' body weight and mammary tumor appearance. Genistein was effective in reducing tumor multiplicity, but it reduced tumor incidence only marginally. Daidzein was less effective in reducing both tumor incidence and multiplicity. To investigate genistein's mechanism of action we determined the topoisomerase II (topo II) activity and detected the phosphotyrosine-containing peptides in the extracts of mammary tissues isolated from control and isoflavone-treated animals. Mammary tumors contained over 60-fold higher topo II enzymatic activity than the mammary glands. Similarly, more tyrosine phosphopeptides were detectable in mammary tumors than in mammary glands. Tissue samples from genistein treated animals contained similar topo II and protein tyrosine kinase (PTK) activities as the control group. These data suggest that mammary tumorigenesis is accompanied by an extensive increase in topo II and PTK activities. The mechanism of chemoprevention by genistein, however, is independent of topo II or PTK inhibition.

AB - Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. Soy-based diets, rich in the isoflavones genistein and daidzein, are thought to protect against breast and prostate cancer. We used the N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis animal model to test the effectiveness of these two isoflavones as chemopreventive agents. Each isoflavone was injected daily into 35-day-old rats for six months while we monitored the animals' body weight and mammary tumor appearance. Genistein was effective in reducing tumor multiplicity, but it reduced tumor incidence only marginally. Daidzein was less effective in reducing both tumor incidence and multiplicity. To investigate genistein's mechanism of action we determined the topoisomerase II (topo II) activity and detected the phosphotyrosine-containing peptides in the extracts of mammary tissues isolated from control and isoflavone-treated animals. Mammary tumors contained over 60-fold higher topo II enzymatic activity than the mammary glands. Similarly, more tyrosine phosphopeptides were detectable in mammary tumors than in mammary glands. Tissue samples from genistein treated animals contained similar topo II and protein tyrosine kinase (PTK) activities as the control group. These data suggest that mammary tumorigenesis is accompanied by an extensive increase in topo II and PTK activities. The mechanism of chemoprevention by genistein, however, is independent of topo II or PTK inhibition.

KW - Carcinogenesis

KW - Chemoprevention

KW - Isoflavones

KW - Protein tyrosine kinase

KW - Topoisomerase II

UR - http://www.scopus.com/inward/record.url?scp=0030507470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030507470&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 3293

EP - 3298

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 A

ER -